reSET® Demo Version 1
reSET Demo Version 1 is a mental health/function therapeutic software (FDA Class II; FDA product code PWE, Computerized Behavioral Therapy Device For Psychiatric Disorders) made by Pear Therapeutics, Inc., granted FDA De Novo DEN160018 on 14 Sep 2017 and listed in FDA GUDID since 25 Nov 2019 (UDI-DI 10851580008194), active as of 23 Oct 2026.
Active
De Novo
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10851580008194 | Date25 Nov 2019 | StatusListed |
| United States | FDA De NovoDENG | NumberDEN160018 | Date14 Sep 2017 | StatusActive |
Official records
- AccessGUDID record 10851580008194
- FDA De Novo database DEN160018
From the FDA record
- Device description
- reSET® is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with substance use disorder (SUD). The Demo Version provides demonstration access to various prescription versions of the reSET product and is not intended for patients.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA De Novo DEN160018 decided 14 Sep 2017 Active
- FDA GUDID UDI-DI 10851580008194 listed 25 Nov 2019 Listed
Timeline
- Granted FDA De Novo DEN160018
- Listed FDA GUDID 10851580008194
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo Active
Specification
- Trade name
- reSET® Demo Version
- Generic name
- Mental health/function therapeutic software, screen-viewed
- Model / reference
- 1
- Primary DI / UDI-DI
- 10851580008194
- De Novo Number
- FDA product code
- PWE
- GMDN term
- Mental health/function therapeutic software, screen-viewed
- Device class
- Class II
- Regulation number
- 882.5801
- GUDID distribution status
- In Commercial Distribution